等待開盤 04-03 09:30:00 美东时间
-0.290
-8.17%
Pulsenmore (NASDAQ:PLSM) reported quarterly losses of $(0.77) per share. The company reported $12.547 million in sales this quarter.
03-30 21:32
Pulsenmore Ltd. press release (PLSM): FY revenue of $12.5M (+380.8% Y/Y). Net loss was $5M for the year ended December 31, 2025, compared to $10M for the year ended December 31, 2024. More on Pulsenm...
03-30 21:29
Pulsenmore publishes investor presentation on FDA-cleared home-use maternal ultrasound platform Pulsenmore highlighted FDA De Novo clearance for its home-use maternal ultrasound system in Nov. 2025, positioning it for U.S. market entry tied to 3.6 million annual deliveries. Platform metrics showed m
03-30 20:49
Full-Year 2025 Financial HighlightsFull year revenue of $12.5 million, representing a 374% increase compared to 2024, including a one-time revenue contribution of $9.6 million related to the GE settlement discussed
03-30 20:36
Pulsenmore FY25 net loss narrows 50% to USD 5 million; revenue jumps to USD 12.5 million Pulsenmore posted a net loss of USD 5 million, narrowing 50% from the prior year. Revenue climbed to USD 13 million, up 374% on a one-time USD 9.6 million contribution tied to a settlement with GE Precision Heal
03-30 20:30
Companies Reporting Before The Bell • Liberty All Star Equity (NYSE:USA) is est...
03-30 19:11
OMER, Israel, March 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results ...
03-25 20:00
OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical ...
02-02 20:13
Gainers Greenwich LifeSciences (NASDAQ:GLSI) shares rose 48.6% to $33.13 durin...
01-22 20:05
Shares of High Roller Technologies Inc (NYSE:ROLR) rose sharply in pre-market t...
01-22 17:46